← Back

$ Value

$23.3M

Shares

86,042

Price

$270

Filed

May 8

Insider

Name

Bradway Robert A

Title

Chairman, CEO and President

CIK

0001396482

Roles

Director Officer

Transaction Details

Transaction Date

2025-05-06

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

86,042

Footnotes

The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. | These shares include 1,424 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. | These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026.

Filing Info

Accession No.

0001127602-25-013788

Form Type

4

Issuer CIK

0000318154

Bradway Robert A's History

Date Ticker Type Value
2026-04-01 BA A $0
2025-10-01 BA A $0
2025-07-01 BA A $0
2025-05-06 AMGN A $0
2025-05-06 AMGN A $23.3M
2025-05-02 AMGN F $704K
2025-05-02 AMGN F $667K
2025-04-30 AMGN F $734K

Other Insiders at AMGN (90d)

No other insider activity at this issuer in the last 90 days.